BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 36517864)

  • 1. ANGPTL4 functions as an oncogene through regulation of the ETV5/CDH5/AKT/MMP9 axis to promote angiogenesis in ovarian cancer.
    Liu Y; Yang R; Zhang Y; Zhu Y; Bao W
    J Ovarian Res; 2022 Dec; 15(1):131. PubMed ID: 36517864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ANGPTL4 accelerates ovarian serous cystadenocarcinoma carcinogenesis and angiogenesis in the tumor microenvironment by activating the JAK2/STAT3 pathway and interacting with ESM1.
    Li YK; Gao AB; Zeng T; Liu D; Zhang QF; Ran XM; Tang ZZ; Li Y; Liu J; Zhang T; Shi GQ; Zhou WC; Zou WD; Peng J; Zhang J; Li H; Zou J
    J Transl Med; 2024 Jan; 22(1):46. PubMed ID: 38212795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The lncRNA TP73-AS1 promotes ovarian cancer cell proliferation and metastasis via modulation of MMP2 and MMP9.
    Wang X; Yang B; She Y; Ye Y
    J Cell Biochem; 2018 Sep; 119(9):7790-7799. PubMed ID: 29904939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retraction Note: ANGPTL4 functions as an oncogene through regulation of the ETV5/CDH5/AKT/MMP9 axis to promote angiogenesis in ovarian cancer.
    Liu Y; Yang R; Zhang Y; Zhu Y; Bao W
    J Ovarian Res; 2023 Jan; 16(1):23. PubMed ID: 36698130
    [No Abstract]   [Full Text] [Related]  

  • 5. Sohlh2 inhibits human ovarian cancer cell invasion and metastasis by transcriptional inactivation of MMP9.
    Zhang H; Hao C; Wang Y; Ji S; Zhang X; Zhang W; Zhao Q; Sun J; Hao J
    Mol Carcinog; 2016 Jul; 55(7):1127-37. PubMed ID: 26153894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological and prognostic value of ETV5 in high-grade serous ovarian cancer.
    Zhang L; Fu R; Liu P; Wang L; Liang W; Zou H; Jia W; Tao L
    J Ovarian Res; 2021 Nov; 14(1):149. PubMed ID: 34736492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PRR11 Overexpression Facilitates Ovarian Carcinoma Cell Proliferation, Migration, and Invasion Through Activation of the PI3K/AKT/β-Catenin Pathway.
    Zhu J; Hu H; Wang J; Yang Y; Yi P
    Cell Physiol Biochem; 2018; 49(2):696-705. PubMed ID: 30165366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of siRNA-silencing of SALL2 gene on growth, migration and invasion of human ovarian carcinoma A2780 cells.
    Miao F; Zhang X; Cao Y; Wang Y; Zhang X
    BMC Cancer; 2017 Dec; 17(1):838. PubMed ID: 29228922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen receptor promotes gastric cancer cell migration and invasion via AKT-phosphorylation dependent upregulation of matrix metalloproteinase 9.
    Zhang BG; Du T; Zang MD; Chang Q; Fan ZY; Li JF; Yu BQ; Su LP; Li C; Yan C; Gu QL; Zhu ZG; Yan M; Liu B
    Oncotarget; 2014 Nov; 5(21):10584-95. PubMed ID: 25301736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiopoietin-like 4 promotes osteosarcoma cell proliferation and migration and stimulates osteoclastogenesis.
    Zhang T; Kastrenopoulou A; Larrouture Q; Athanasou NA; Knowles HJ
    BMC Cancer; 2018 May; 18(1):536. PubMed ID: 29739381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ETV5 transcription factor is overexpressed in ovarian cancer and regulates cell adhesion in ovarian cancer cells.
    Llauradó M; Abal M; Castellví J; Cabrera S; Gil-Moreno A; Pérez-Benavente A; Colás E; Doll A; Dolcet X; Matias-Guiu X; Vazquez-Levin M; Reventós J; Ruiz A
    Int J Cancer; 2012 Apr; 130(7):1532-43. PubMed ID: 21520040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic targeting of PELP1 prevents ovarian cancer growth and metastasis.
    Chakravarty D; Roy SS; Babu CR; Dandamudi R; Curiel TJ; Vivas-Mejia P; Lopez-Berestein G; Sood AK; Vadlamudi RK
    Clin Cancer Res; 2011 Apr; 17(8):2250-9. PubMed ID: 21421858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of matrix metalloproteinase 9 by small interfering RNA inhibits the tumor growth of ovarian epithelial carcinoma in vitro and in vivo.
    Guo F; Tian J; Cui M; Fang M; Yang L
    Mol Med Rep; 2015 Jul; 12(1):753-9. PubMed ID: 25738807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CNOT7 modulates biological functions of ovarian cancer cells via AKT signaling pathway.
    Yu J; Hu X; Chen X; Zhou Q; Jiang Q; Shi Z; Zhu H
    Life Sci; 2021 Mar; 268():118996. PubMed ID: 33412213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic silencing of the dual-role signal mediator, ANGPTL4 in tumor tissues and its overexpression in the urothelial carcinoma microenvironment.
    Hsieh HY; Jou YC; Tung CL; Tsai YS; Wang YH; Chi CL; Lin RI; Hung SK; Chuang YM; Wu SF; Li C; Shen CH; Chan MWY; Hsu CD
    Oncogene; 2018 Feb; 37(5):673-686. PubMed ID: 29035390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TCP1 regulates PI3K/AKT/mTOR signaling pathway to promote proliferation of ovarian cancer cells.
    Weng H; Feng X; Lan Y; Zheng Z
    J Ovarian Res; 2021 Jun; 14(1):82. PubMed ID: 34162426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA-binding protein IGF2BP2 enhances circ_0000745 abundancy and promotes aggressiveness and stemness of ovarian cancer cells via the microRNA-3187-3p/ERBB4/PI3K/AKT axis.
    Wang S; Li Z; Zhu G; Hong L; Hu C; Wang K; Cui K; Hao C
    J Ovarian Res; 2021 Nov; 14(1):154. PubMed ID: 34774079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exosomes transferring long non-coding RNA FAL1 to regulate ovarian cancer metastasis through the PTEN/AKT signaling pathway.
    Zhang Q; Len TY; Zhang SX; Zhao QH; Yang LH
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):43-54. PubMed ID: 31957817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ANGPTL4 regulates ovarian cancer progression by activating the ERK1/2 pathway.
    Xu J; Wu F; Zhu Y; Wu T; Cao T; Gao W; Liu M; Qian W; Feng G; Xi X; Hou S
    Cancer Cell Int; 2024 Feb; 24(1):54. PubMed ID: 38311733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of metastasis-associated in colon cancer 1 inhibition by small hairpin RNA on ovarian carcinoma OVCAR-3 cells.
    Zhang R; Shi H; Chen Z; Wu Q; Ren F; Huang H
    J Exp Clin Cancer Res; 2011 Sep; 30(1):83. PubMed ID: 21923915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.